Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode (CT&E-RCT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02823041 |
Recruitment Status :
Recruiting
First Posted : July 6, 2016
Last Update Posted : September 2, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Schizophrenia Schizophreniform Disorder Schizoaffective Disorder | Behavioral: Cognitive Training Behavioral: Aerobic Exercise Behavioral: Case management and supportive psychotherapy Behavioral: Individual Placement and Support | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode |
Study Start Date : | September 2016 |
Estimated Primary Completion Date : | June 2023 |
Estimated Study Completion Date : | December 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Cognitive Training & Exercise
This arm involves a combination of systematic computerized cognitive training plus 150 minutes per week of aerobic exercise. All participants will also receive individual case management and supportive psychotherapy as well as Individual Placement and Support.
|
Behavioral: Cognitive Training
24 weeks of systematic computerized cognitive training, 4 hours per week. The first 12 weeks involves neurocognitive training, using auditory training exercises from Posit Science Brain HQ. The 2nd 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. A weekly one-hour Bridging Skills Group is designed to aid generalization of training to everyday life situations.
Other Name: cognitive remediation Behavioral: Aerobic Exercise Aerobic exercise occurs as two 45-minute sessions at the clinic and two 30-minute sessions at home weekly. Exercise involves an adaptation of interval training, including a variety of calisthenics that can be done without specialized equipment. Intensity of aerobic exercise is tailored to maintain an individualized target heart rate zone and is monitored by a heart rate recorder.
Other Name: physical exercise Behavioral: Case management and supportive psychotherapy An individual therapist will provide weekly case management and therapy targeting the individual psychological problems and everyday functioning needs of the patient Behavioral: Individual Placement and Support An job/school specialist will use the Individual Placement and Support model to help participants return to school or work and provide ongoing outreach support.
Other Name: supported education/employment |
Active Comparator: Cognitive Training
This arm includes the same systematic computerized cognitive training as the experimental condition, but without the additional aerobic exercise. All participants will also receive individual case management and supportive psychotherapy as well as and Individual Placement and Support.
|
Behavioral: Cognitive Training
24 weeks of systematic computerized cognitive training, 4 hours per week. The first 12 weeks involves neurocognitive training, using auditory training exercises from Posit Science Brain HQ. The 2nd 12 weeks involves social cognitive training, using the Posit Science SocialVille modules. A weekly one-hour Bridging Skills Group is designed to aid generalization of training to everyday life situations.
Other Name: cognitive remediation Behavioral: Case management and supportive psychotherapy An individual therapist will provide weekly case management and therapy targeting the individual psychological problems and everyday functioning needs of the patient Behavioral: Individual Placement and Support An job/school specialist will use the Individual Placement and Support model to help participants return to school or work and provide ongoing outreach support.
Other Name: supported education/employment |
- Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) overall composite score [ Time Frame: 6 months ]The Overall Composite score from the MCCB is a summary of cognitive performance across seven domains.
- Global Functioning Scale: mean of Role and Social ratings [ Time Frame: 6 months ]A 10-point rating scale to evaluate role and social functioning
- Brain-derived neurotrophic factor (BDNF) [ Time Frame: 6 months ]BDNF is a key neurochemical factor known to mediate the effects of exercise in the brain
- YMCA fitness test [ Time Frame: 6 months ]Cardiorespiratory fitness and muscular endurance measured by the YMCA fitness test
- VO2 Max [ Time Frame: 6 months ]A cardiovascular fitness measure derived from a treadmill test protocol
- Role Functioning Scale [ Time Frame: 6 months ]7-point ratings of Work Productivity, Independent Living, Social Relationships, Family Relationships

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- a first episode of a psychotic illness that began within the past two years;
- a diagnosis by DSM-5 of schizophrenia, schizoaffective disorder, mainly depressed type, or schizophreniform disorder;
- sufficient acculturation and fluency in the English language to avoid invalidating research measures; and
- residence likely to be within commuting distance of the UCLA Aftercare Research Program.
Exclusion Criteria:
- inability to participate in aerobic exercise;
- evidence of a known neurological disorder (e.g., epilepsy) or significant head injury;
- evidence of moderate or severe alcohol or substance use disorder within the six months prior to the first episode or evidence that substance abuse triggered the psychotic episode or makes the schizophrenia diagnosis ambiguous; or
- mental retardation, i.e. estimated premorbid IQ less than 70.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02823041
Contact: Joseph Ventura, Ph.D. | 310-206-3142 | JVentura@mednet.ucla.edu | |
Contact: Luana Turner, Psy.D. | 310-206-3142 | LTurner@mednet.ucla.edu |
United States, California | |
University of California, Los Angeles | Recruiting |
Los Angeles, California, United States, 90095-6968 | |
Contact: Luana R Turner, Psy.D. 310-206-3142 luana@ucla.edu | |
Contact: Joseph Ventura, Ph.D. 310-206-3142 jventura@mednet.ucla.edu | |
Principal Investigator: Keith H Nuechterlein, Ph.D. | |
Sub-Investigator: Joseph Ventura, Ph.D. | |
Sub-Investigator: Sarah McEwen, Ph.D. | |
Sub-Investigator: Kenneth L Subotnik, Ph.D. | |
Sub-Investigator: Laurie Casaus, M.D. | |
Sub-Investigator: Michael Boucher, M.D. | |
Sub-Investigator: Gerhard Hellemann, Ph.D. |
Principal Investigator: | Keith Nuechterlein, Ph.D. | UCLA Department of Psychiatry & Biobehavioral Sciences |
Responsible Party: | Keith Nuechterlein, Ph.D., Principal Investigator, University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT02823041 |
Other Study ID Numbers: |
R01MH110544 ( U.S. NIH Grant/Contract ) |
First Posted: | July 6, 2016 Key Record Dates |
Last Update Posted: | September 2, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | After primary results have been published, de-identified data for primary outcome variables will be available for sharing. |
cognitive training aerobic exercise neurotrophic factors randomized controlled trial functional outcome |
Disease Schizophrenia Psychotic Disorders |
Pathologic Processes Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders |